Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Customer Guest
Login | Register
Login | Register|Forgot password?
Appointment of Mr. Navjyoti Kumar Jha as internal auditor of the company for the F.Y. 2026-27.more...
Standalone audited financial results of the company for the quarter and year ended on 31 March 2026.more...
1. Considered and approved the standalone audited financial results of the company for the quarter and financial year ended 31st March 2026; \r\n2. C...more...
Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia t...more...
Certificate under Regulation 74 (5) of SEBI (DP) Regulations 2018 for the quarter ended on 31st March 2026.more...
As of March 2026 46.06% is owned by Indian Promoters and 53.94% by Public. Top Promoter holding highest number of shares of Genomic Valley B...more...
Disclosure made by Promoters and Promoters group of the company under Regulation 31(4) of SEBI (substantial Acquisition of Shares and Takeovers) Regu...more...
Disclosure made by Promoters and Promoters group of the company under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeov...more...
Cessation of Mr. Ashok Kumar (DIN: 07647876) from the directorship of the company.more...
Please find enclosed herewith the financial results for the Quarter and Nine Months ended 31st December 2025 pursuant to Regulation 33 of th...more...
Please find enclosed herewith the Outcome of the Board Meeting dated 15/01/2026 for your reference.more...
As of December 2025 46.06% is owned by Indian Promoters and 53.94% by Public. Top Promoter holding highest number of shares of Genomic Valle...more...
Certificate under Regulation 74 (5) of SEBI (DP) Regulations 2018 for the quarter ended on 31st December 2025.more...
Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/01/2026 inter alia t...more...
Submission of voting results of 31st Annual General Meeting of the Company under Regulation 44(3) of the SEBI (listing Obligations & Disclosure Requi...more...
Submission of voting results of 31st Annual General Meeting of the Company under Regulation 44(3) of the SEBI (listing Obligations & Disclos...more...
BOARD MEETINGS Company Name : Betala Global Sec. Date : 06-07-2026